Concepedia

Author

Olivier Legrand

Sorbonne Université

Also Known As

Anne Vekhoff, Olivier Legrand

18

Publications

295

Citations

9

H-Index

13

Concepts

All Affiliations

Sorbonne UniversitéHôpital Saint-AntoineHôpital Saint-LouisAssistance Publique – Hôpitaux de ParisCentre Hospitalier Universitaire de Caen Normandie
OL

About

Olivier Legrand is an author at Sorbonne Université specializing in hematology, health sciences, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

47

2

Medicine

2

2

47

3

Blood Transplantation

1

1

32

4

Immunology

1

1

32

5

Pathology

1

1

15

Olivier Legrand

×

7

Publications

214

Citations

7

H-Index

YearCitations

Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells

Hiba El Hajj, Zeina Dassouki, Caroline Berthier,

Blood

2015

116

10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial

Michael Lübbert, Pierre W. Wijermans, Michal Kiciński,

The Lancet Haematology

2023

32

When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group)

Bruno Cassinat, Stéphane de Botton, Charikleia Kelaïdi,

Leukemia Research

2009

15

Multidrug Resistance (MDR) Gene Expression in Acute Non Lymphoblastic Leukemia: Sequential Analysis

Jean‐Pierre Marie, Olivier Legrand, Domenico Russo,

Leukemia & lymphoma/Leukemia and lymphoma

1992

15

Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS

Thomas Cluzeau, Fabio Guolo, Edmond Chiche,

Blood Advances

2024

14

Olutasidenib (FT-2102) in Combination with Azacitidine Induces Durable Complete Remissions in Patients with mIDH1 Acute Myeloid Leukemia

Jörge E. Cortes, Jordi Esteve, Ashish Bajel,

Blood

2021

11

Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial

Fabio Efficace, Michal Kiciński, Corneel Coens,

Blood

2024

11

Page 1